MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

Home > LMB In The News > Halogen bonding helps design new drugs

Halogen bonding helps design new drugs

Published on

“Scientists at the University of Tübingen, in cooperation with the MRC Laboratory of Molecular Biology in Cambridge / UK, have now demonstrated that halogen bonding can be used to identify potential drug candidates for cancer treatment. Dr. Rainer Wilcken and Prof. Frank Böckler in collaboration with Dr. Andreas Joerger and Prof. Sir Alan Fersht…” More…